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Edited by Judit Ova´diAbstract We investigated the enzyme activity of peptidyl prolyl
cis/trans isomerases (PPIases) in brain, testis, lung, liver, and
mouse embryonic ﬁbroblasts (MEF) of Pin1+/+ and Pin1/
mice. The aim of this study is to determine if other PPIases
can substitute for the loss of Pin1 activity in Pin1/ mice and
what inﬂuence Pin1 depletion has on the activities of other PPI-
ases members. The results show that high PPIase activities of
Pin1 are found in organs that have the tendency to develop
Pin1 knockout phenotypes and, therefore, provide for the ﬁrst
time an enzymological basis for these observations. Furthermore
we determined the speciﬁc activity (kcat/KM) of endogenous Pin1
and found that it is strongly reduced as compared with the
recombinant protein in all investigated organs. These results
suggest that posttranslational modiﬁcations may inﬂuence the
PPIase activity in vivo. The activities originating from cyclophi-
lin and FKBP are not inﬂuenced by the Pin1 knockout, but a ba-
sal enzymatic activity towards phosphorylated substrates could
be found in Pin1/ lysates. Real time PCR experiments of all
PPIases in diﬀerent mouse organs and MEF of Pin1+/+ and
Pin1/ mice support the ﬁnding and reveal the speciﬁc expres-
sion proﬁles of PPIases in mice.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Peptidyl prolyl cis/trans isomerases (PPIases) accelerate the
cis/trans isomerization of peptidyl prolyl bonds in peptides
and proteins both in vivo and in vitro [1–3]. According to their
sequence homologies and sensitivities to speciﬁc inhibitors,
PPIases can be divided into three families, cyclophilin, FKBP,
and parvulins. Pin1 belongs to the parvulin family. It is the
only PPIase known to have a high speciﬁcity to substrates with
phosphorylated serine and threonine side chains preceeding
proline [4,5]. Pin1 consists of a PPIase and a WW domainAbbreviations: pS, phosphoserine; pT, phosphothreonine; PPIase,
peptidyl prolyl cis/trans isomerase
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doi:10.1016/j.febslet.2006.04.087which interact with phosphorylated (pS)P- and phosphothreo-
nine (pT)P-motifs in peptides and proteins [5,6].
Pin1 controls the functions of phosphorylated proteins, such
as cell cycle regulatory molecules: CDC25C [7], Wee1 [8], Myt1
[9], CK2 [10], Plk1 [11], tis21 [12], cyclin D1 [13], Raf-1 [14];
transcription factors: NFAT [15], c-Jun [16], c-Fos [17],
p54nrb [18], the hSpt5 subunit of the DRB sensitivity-inducing
factor [19], C-terminal domain of RNA polymerase II [20];
tumor suppressor proteins: p53 [17], p73 [21]; steroid receptors:
SRC-3 [22]; mouse embryonic midline and left/right axial
development: Sil [23]; and chromatin condensation: topoiso-
merase IIa [10].
Although the depletion of Pin1 in Saccharomyces cervices
and Candida albicans caused cell death [24,25], mice, [26] Dro-
sophila melanogaster [26,27] and a strain of S. cervices C110
[28] lacking Pin1 were viable. The phenotypes in Pin1/mice
include a higher risk of developing Alzheimer’s disease [29],
testicular and retinal atrophies, and that the breast epithelial
compartment failed to undergo the normal changes associated
with pregnancy [13,27]. In other organs such as lung and liver,
no pathological changes have been observed so far. It has been
proposed that Pin1/ mice are viable because other PPIases
might act for Pin1 and thereby help the organisms to develop.
Cyclophilin A and parvulin 14, the second parvulin-type of
PPIases, are slightly overexpressed in Pin1-depletion yeast
and mouse embryonic ﬁbroblasts (MEF), respectively [28,30].
In the human genome, a Pin1 homologue has been identiﬁed
which is about 90% identical to Pin1 [31]. The corresponding
mouse protein with the same high level of identity has not been
investigated, but no cross reactions of polyclonal Pin1 antibod-
ies could be observed in Pin1/ mouse tissues [27], question-
ing the expression of this gene in mice.
This article describes the analysis of all cyclophilin- and
FKBP-type PPIases known in mice, and compares the mRNA
levels and activities of PPIases in organs that show a strong
phenotype, such brain and testis, with organs having no pro-
nounced phenotypes, such as lung and liver.2. Materials and methods
Substrates were obtained from Bachem (Weil am Rhein, Germany).
Cyclosporine A was purchased from Wako Pure Chemicals, Ltd (Ja-
pan). FK506 was a gift from Astellas Pharma Inc. (Tokyo, Japan).
Chymotrypsin and trypsin were purchased from Sigma–Aldrich
(Tokyo, Japan).blished by Elsevier B.V. All rights reserved.
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Pin1-KO mice were created from the 129SV ES cells and then the
Pin1 gene deletion was transferred into an isogenic C57BL/6J back-
ground. The wild type mice were obtained from the littermates.
MEF were produced and cultured as previously described [27,30].
2.2. RNA preparation, cDNA synthesis, and real time PCR analysis
Total RNA from 100 to 200 mg of tissue was prepared by using Sep-
azol RNA extraction solution (Nakalai Tesque Inc., Kyoto, Japan)
following the protocol provided by the manufacturer. To increase
RNA purity, the extraction protocol was repeated. The quality of
the total RNA was checked by denaturing agarose gel electrophoresis
containing 1.5% formaldehyde. Total RNA concentration and purity
was determined by UV–Vis spectroscopy with the Bio-Rad SmartSpec
3000 system (California, USA). cDNA synthesis was performed by
using TaqMan reverse transcription reagents (Applied Biosystems,
New Jersey, USA) as instructed by the manufacturer. All sequences
of the primer pairs used for real time PCR were obtained from the
PrimerBank [32]. Real Time PCR was performed with the 7300 Real
Time PCR System (Applied Biosystems, Warrington, UK). Total sam-
ple volume was 25 ll. The real time PCR protocol consisted of two ini-
tial steps (50 C for 2 min, followed by 94 C for 5 min), 40 cycles of
DNA ampliﬁcation (94 C for 1 min, 57 C for 45 s, 72 C for 45 s)
and a PCR-product dissociation stage for quality control. The quality
of the PCR products was further checked by 2.5% agarose gel electro-
phoresis. In all cases, single bands of the expected size were observed.
Relative transcript quantities were calculated as DCT values, as recom-
mended by the manufacturer with GAPDH as the endogenous refer-
ence ampliﬁed from the samples.
2.3. Preparation of protein samples for Western blot and PPIase assay
Freshly prepared mouse organs were cut into small pieces (approx.
50–100 mg) and frozen in liquid nitrogen. Frozen tissues were then
thawed in 500 ll ice cold NP40 buﬀer (50 mM Tris, pH 7.5, 150 mM
NaCl, 1% (v/v) NP40, 5 mM EDTA, 1 mM PMSF, 50 mM NaF,
1 mM Na3VO4) supplemented with protease inhibitor cocktail (Naka-
lai Tesque, Inc. Kyoto, Japan). The material was homogenized by ul-
tra-turrax T8 (IKA, Staufen, Germany) for 15 s at the highest speed
setting. The lysate was diluted with NP40 buﬀer to a total volume of
2.5 ml. Immediately after dilution, the lysate was divided into aliquots
of 50 ll, subsequently frozen in liquid nitrogen, and stored until used
at 80 C. Insoluble parts in the lysates were removed before use by
centrifugation of the thawed sample for 20 s at 21000 · g. The protein
concentration of the samples was determined by using the BCA Pro-
tein Assay Kit (Pierce, Illinois, USA) according to the manufacturer’s
protocol. The total protein concentrations for all samples were be-
tween 2 and 7 mg/ml.
2.4. PPIase assay
The PPIase assay was performed by the protease-coupled assay de-
scribed earlier [1,33]. Total sample volume was 1500 ll, sample buﬀer
was 35 mM HEPES, pH 7.5. Stock solutions of all substrates (30 mg/
ml) were prepared in 0.47 M LiCl/TFE (anhydrous). Stock solutions of
proteases (100 mg/ml for chymotrypsin and 50 mg/ml for trypsin) were
in 35 mM HEPES, pH 7.8. Insoluble materials from all stock solutions
were removed by centrifugation before use.
To measure the total cyclophilin-related PPIase activity, the sub-
strate Suc-AAPF-pNA was used. In addition to the substrate
(0.03 mg/ml) and protease (chymotrypsin, 0.2 mg/ml), a ﬁnal concen-
tration of 33 lM FK506 was present during the measurement to inhi-
bit FKBP-related activities. The FKBP activity was measured with the
substrate Suc-ALPF-pNA (0.03 mg/ml) in the presence of chymotryp-
sin (0.2 mg/ml) and 33 lM cyclosporine A. To determine the PPIase
activity originating from Pin1, the phosphorylated substrate Ac-
AA(pS)PR-pNA (0.02 mg/ml) in combination with trypsin (0.1 mg/
ml), 33 lM cyclosporine A and 33 lM FK506 was employed. For a
typical measurement, the sample buﬀer was incubated in a tempera-
ture-controlled cuvette holder at 10 C for 4 min. After the inhibitors
and substrate were mixed, the reaction was started by the injection
of the protease. After the initial burst phase where the all-trans pep-
tides were cleaved, the protein sample was added to the reaction.
The reaction was recorded with an Agilent 8453 UV–Vis spectropho-
tometer (California, USA), and the signal diﬀerence between 390 and
510 nm was used to calculate the ﬁrst-order rate constants.3. Results
3.1. PPIase activity against phosphorylated substrates
Knockout of Pin1 in mice results in organ-speciﬁc pheno-
types. Physiological and histological cellular changes are ob-
served in the brain, testis, and ovary; whereas, other organs
do not show noticeable eﬀects [13,27,34]. To investigate
whether these diﬀerent eﬀects of Pin1 are due to a speciﬁc
backup by other PPIases, the PPIase activities in brain, testis,
lung, and liver and an embryonic cell line were compared in
WT and Pin1/ mice.
The observed enzymatic Pin1 activities varied strongly with-
in the investigated organs (Fig. 2). The PPIase activity was
normalized to the total protein concentration of each respec-
tive lysate. The activity is shown in arbitrary units, calculated
by using the observed ﬁrst-order rate constant of the enzymat-
ically catalyzed reaction (kobs) subtracting the rate constant of
the uncatalyzed reaction (kuncat) and dividing that value by the
total protein concentration of the lysate in the sample. Almost
no Pin1 activity was found in liver and lung; whereas, the PPI-
ase activity of Pin1 in brain and testis was substantial. To
prove that the observed activity is exclusively produced by
Pin1, we analyzed cell lysates obtained from Pin1/ mouse tis-
sues. No PPIase activity was found when the phosphorylated
substrate was used with FK506 and cyclosporine A in the reac-
tion mixture. From this result, the question arises as to how
the enzymatic activity of Pin1 is regulated. The same lysates
as prepared for the activity assays were used to determine
the amount of Pin1 by Western blot (Fig. 2A). The absolute
amount of endogenous Pin1 in the lysate was determined by
comparing the intensity of the Pin1 band with the bands from
known amounts of recombinant Pin1 on the same Western
blot gel. This enabled us to estimate the speciﬁc activity of
Pin1 in the diﬀerent tissues. As shown in Fig. 2B, the kcat/
KM values of Pin1 were very similar in all tissues. We also
checked the PPIase activity against the phosphorylated sub-
strate without the addition of CsA or FK506. The lack of
FK506 did not change the activity levels in the WT and
Pin1/ mouse lysates, although the activity was increased
when CsA was not added into the mixture. These results were
observed to the same extent in the WT and Pin1/ lysates.
Interestingly, the speciﬁc activity of Pin1 in the lysates was
about 4–9 times lower than that found for the recombinant pro-
tein (Fig. 3). The WT mouse lysates included the natural li-
gands of Pin1, which could act as a competitive inhibitor to
the in vitro substrate used for the activity assays. We therefore
checked whether incubation of the recombinant GST-Pin1 with
Pin1/ MEF cell lysates reduced the speciﬁc activity. The ob-
served 50% reduction of the speciﬁc activity (Fig. 3) can be ex-
plained by the high ionic content of the lysis buﬀer used.
3.2. PPIase activities of cyclophilins and FKBPs
The cyclophilin-related PPIase activity in the investigated tis-
sues is quite equally distributed (Fig. 4). The use of the Suc-
AAPF-pNA substrate in combination with a high concentra-
tion of FK506 ensured that no activity originating from FKBP
or Pin1 inferred with the measurement. The highest activity was
found in MEF and Brain tissue. The activity proﬁle of FKBP
was similar to that of the cyclophilin-related activity (Fig. 5),
with the diﬀerence that the highest activity was found in testis
lysates. The small diﬀerences found in the activity levels be-
tween WT and Pin1/ are within the range of error, which is
Fig. 1. PPIase activity of Pin1 against Ac-AA(pS)PR-pNA substrate measured in tissue lysates of brain, testis, lung, liver, and MEF. The measured
activity was normalized to the total protein concentration of the lysate (n = 4). To avoid any inﬂuence from cyclophilins and FKBPs present in the
lysate, 33 lM cyclosporine A and 33 lM FK506 were added to all reactions.
Fig. 2. Pin1 activity in tissue lysates of brain, testis, lung, liver, and MEF normalized to the total amount of endogenous Pin1 in the lysates. The
expression of Pin1 in these tissues was shown by immunoblot (A). The second-order rate constants were calculated by dividing the ﬁrst-order rate
constant kenz by the Pin1 concentration present in the assay (B). The error of the values is the combination of the error made in estimating the
absolute Pin1 protein amount by Western blot (S.E.M.; ±30%, n = 4) and the error range of the PPIase assay (S.E.M.; ±10%, n = 4).
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concentration (S.E.M. = ±20%) and the error made in deter-
mining the PPIase activity (S.E.M. = ±10%). The major diﬀer-
ence between the cyclophilin and FKBP activity levels in the
diﬀerent tissues is the approximately 20- to 30-fold higher
cyclophilin-related activity.
3.3. mRNA level of PPIases in mouse organs
We determined the mRNA levels of all individual FKBPs
and cyclophilins in Table 1 to ensure that the similar observed
PPIase activities in Pin1+/+ and Pin1/ lysates are not a direct
consequence of a simultaneous upregulation of one set of PPI-
ases compensated for by a downregulation of another set of
PPIases.In Figs. 7 and 8, the overall expressions of cyclophilins and
FKBPs are shown for four diﬀerent WT organs (brain, testis,
lung, and liver) and an MEF cell line normalized to the
expression of the endogenous control GAPDH. The expres-
sion levels of PPIases Nos. 16, 30, and 31 were below the
detection limit of the method for all organs and were there-
fore excluded. No PPIases were exclusively expressed highly
in lung and liver as could be expected for a PPIase that spe-
ciﬁcally substitutes Pin1, and thereby represses the Pin1-spe-
ciﬁc phenotype in these organs. We also checked the
mRNA level of a Pin1L a gene with very high homology to
Pin1, which was suspected to be responsible for the lack of
phenotype in Pin1/ D. melanogaster and mice [31], but
no expression in any organ could be found. It shows that this
Fig. 3. Pin1 activity of GST-Pin1 (A) compared with the activity of GST-Pin1 preincubated in Pin1/ MEF lysates (B) or in lysis buﬀer plus 0.1 mg
BSA (C). For easier comparison, the activity of endogenous Pin1 in MEF is also included (D). The error of the values (A–C) is the combination of the
error of estimating the absolute Pin1 protein by UV–Vis spectroscopy (S.E.M.; ±10%, n = 4) and the error range of the PPIase assay (S.E.M.; ±10%,
n = 4).
Fig. 4. Comparison of the PPIase activity of cyclophilins against Suc-AAPF-pNA substrate measured in tissue lysates of brain, testis, lung, liver, and
MEF of Pin1 WT and Pin1/. The measured activity was normalized to the total protein concentration of the lysate (n = 4). To avoid any inﬂuence
from FKBPs present in the lysate, 33 lM FK506 was added to all reactions.
Fig. 5. Comparison of the PPIase activity of FKBPs against Suc-ALPF-pNA substrate measured in tissue lysates of brain, testis, lung, liver, and
MEF of Pin1 WT and Pin1/. The measured activity was normalized to the total protein concentration of the lysate (n = 4). To avoid any inﬂuence
from cyclophilins present in the lysate, 33 lM cyclosporine A was added to all reactions.
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Fig. 6. Real time PCR analysis of Pin1 in brain, testis, lung, liver, and MEF. CT-values were normalized to the expression of the endogenous
GAPDH control (n = 3).
Fig. 7. Real time PCR analysis of cyclophilins in brain, testis, lung, liver, and
endogenous GAPDH control in MEF (n = 3).
Table 1
Swissprot entries of PPIases in mouse
Cyclophilin FKBP
No. Swissprot/Gen name No. Swissprot/Gen name
1 P17742/Ppia 17 P26883/Fkbp1a
2 Q99KR7/Ppif 18 Q9Z2I2/Fkbp1b
3 Q9QZH3/Ppie 19 P30416/Fkbp4
4 Q9ERU9/Ranbp2 20 Q64378/Fkbp5
5 P24369/Ppib 21 P45878/Fkbp2
6 Q9CR16/Ppid 22 Q62446/Fkbp3
7 P30412/Ppic 23 P59024/Fkbp14
8 Q9D868/Ppih 24 Q61576/Fkbp10
9 Q13427/Ppig 25 Q9Z247/Fkbp9
10 P30415/Nktr 26 Q9D1M7/Fkbp11
11 Q9D0W5/Ppil1 27 Q91XW8/Fkbp6
12 Q812D2/Ppil3 28 O54998/Fkbp7
13 Q9D787/Ppil2 29 O35465/Fkbp8
14 Q9D3J1/Ppil4 30 O08915/Aip
15 Q9D6D8/Ppil6 31 Q924K1/Aipl
16 AK014025a
aGenBank Accession Number.
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as a pseudogene.
Despite the diﬀerences in other activities, the mRNA level of
Pin1 is quite similar in all investigated organs (Fig. 6). The
maximal diﬀerence of DDCT = 1.9 can be found between testis
and MEF.
In Fig. 9, the average DDCT values for FKBP in WT brain
compared to Pin1/ brain are exemplarily shown. Three dif-
ferent mice were used to prepare mRNA from whole brain tis-
sue. The CT values are normalized to the endogenous GAPDH
level. The only FKBP with a jDDCTj larger than 2 is Fkbp6
(DDCT = 2.2). A DDCT value of 2 corresponds to a 4-fold
higher level of expression in the Pin1/ brain. The total
amount of Fkbp6 mRNA in the brain (Fig. 8) is very low.
Accordingly, the amount of Fkbp6 protein in the brain is be-
low the detection level of the available antibody (data not
shown) [35]. In addition to Fkbp6 expression in the brain,
Fkbp7 in primary MEF cells shows a higher expression level
in the knockout cells, with a DDCT value of 2.8. This diﬀerence
translates to an approximately 7-fold increase in mRNA inMEF. CT-values were normalized to the expression of the level of the
Fig. 8. Real time PCR analysis of FKBPs in brain, testis, lung, liver, and MEF. CT-values were normalized to the expression of the level of the
endogenous GAPDH control in MEF (n = 3).
Fig. 9. DDCT analysis of the mRNA level of FKBPs in brain normalized to the expression of the endogenous GAPDH control (n = 3).
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show a change in the jDDCTj values larger than 2.
Not all Pin1-related physiological eﬀects are exclusively
mediated through its PPIase domain [10,15,36]. We therefore
checked the mRNA levels of proteins possessing a WW do-
main with comparable substrate speciﬁcity to Pin1. According
to the consensus sequence postulated [37–39], ﬁve proteins in
mice were found to have such a (pT/pS)P-speciﬁc WW domain
(Table 2). Real time PCR experiments showed, however, that
none of these proteins have a diﬀerence in jDDCTj values be-
tween WT and Pin1/ tissues larger than 2.Table 2
Swissprot entries of proteins containing a WW domain with a similar
substrate speciﬁcity as the Pin1-WW domain
No. Swissprot/Gen name
1 Q91wl8/Wwox
2 Q8C7V0/1300018I05Rik
3 Q9JHC1/Fnbp4
4 P46935/Nedd4
5 P59114/Pcif13.4. Structural comparison
The ﬁnding that two FKBPs are more highly expressed in
Pin1/ tissues as compared with their WT counterparts led
us to investigate the structural similarities of Pin1 and FKBP
in more detail. We used the available mammalian FKBP struc-
tures found in the RCSB-databank.
By superimposing the central b2 and b6 b-sheets in the
FKBP domains with the two central b-sheets of the Pin1 (b1
and b4) PPIase domain and the small a-helix positioned over
the active sites (a1 and a4 for FKBP and Pin1, respectively)
we could check whether a cluster of positively charged side
chains can be found in the respective FKBP in a position close
to the b1/a1 phosphate/sulfate binding loop of Pin1. We found
a high similarity between the phosphate speciﬁcity determining
loop in Pin1 and the loop connecting the b5 and b6 sheets of
the second FKBP domain of Fkbp5 (FKBP51) and Fkbp4
(FKBP52) (Fig. 10). The ﬁnding that this loop in the named
FKBP is capable of binding negatively charged ligands is
underlined by the fact that in the crystal structure of FKBP51,
a sulfate ion is bound at this position (PDB code: 1KTO) [40].
Homology searches revealed that this positive charged patch is
also present in FKBP14.
Fig. 10. Structural comparison of Pin1 (left, pdb code: 1Pin) and the second PPIase domain of FKBP51 (right, pdb code: 1Kto). The Structures were
superimposed by aligning the central b2, b6 b-sheets in the second FKBP domain of Fkbp6 with the two central b-sheets of the Pin1 (b1 and b4)
PPIase domain; additionally, the small a-helix positioned over the active sites (a1 and a4 for Fkbp6 and Pin1, respectively) of both enzymes were also
included in the alignment. The superimposition (middle) shows the two arginine residues of Pin1 (R68 and R69) and the two lysine residues of Fkbp6
(K230 and K232), in complex with their respective sulfate ions present in the crystal structure.
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An earlier work showed that in primary MEF a second
member of the parvulin type family (parvulin 14) had slightly
higher mRNA and protein levels in Pin1/ MEF cells [30]. In
contrast to the brain and testis tissues of Pin1/ mice, primary
MEF cells show only a moderate phenotype [27], and, there-
fore, might not be suitable for investigating the question
whether other PPIases act in the place of Pin1 in Pin1/ mice.
We have therefore compared the PPIase activities between WT
and Pin1/ mice, in those organs that develop Pin1/ related
phenotypes and those without phenotypes.
The most striking observation was that even though the
mRNA level of Pin1 is similar in the organs that show pheno-
types in the Pin1/ mice (e.g., brain and testis, and to a lesser
extent MEF) and the organs without phenotypes (lung and li-
ver) the Pin1 activity was very diﬀerent (Fig. 1). High Pin1
activity levels were only found in those organs that show sig-
niﬁcant phenotypes in Pin1/ mice. Almost no Pin1 PPIase
activity was observed in organs such as the liver and lung
where no Pin1/phenotypes have been reported. Even though
the total activity is much higher in brain, testis, and to some
extent in MEF, the speciﬁc activity is very similar in all organs.
The results show that the observed diﬀerences are a direct con-
sequence of the higher proportion of Pin1 compared with the
total protein (Fig. 2). These results suggest that Pin1 activity
is mainly controlled by its expression level but not by the mod-
iﬁcation. This ﬁnding provides the ﬁrst enzymologically based
explanation for the organ speciﬁcity of the Pin1 phenotypes.
Until now, the means whereby the Pin1 function is regulated
has not been well known. It has been shown, however, that the
WW domain can be phosphorylated at a serine in position 16,
and as a consequence the domain is unable to bind to its native
substrates [36]. The phosphorylation at serine 65 in the PPIases
domain, on the other hand, does not impair the PPIase func-
tion [11]. Our results clearly show that the PPIase activity of
endogenous Pin1 is lower than that of recombinant Pin1
(Fig. 3). This eﬀect was observed to the same extent in all tis-
sues. The reduced activity is not caused by natural Pin1 li-
gands, which could compete with the in vitro substrate, since
the activity of recombinant Pin1 incubated with Pin1/ ly-
sates does not produce such results. Amazingly, even though
the Pin1-speciﬁc activity (kcat/KM) is reduced in the organs,
the total activity is only between 3- to 10-fold lower than the
combined activity of the FKBPs. In contrast, cyclophilin-re-
lated activity is about 30-fold higher than the FKBP activity.
This diﬀerence can be explained by two facts: ﬁrst, the speciﬁcactivities of most cyclophilin-type PPIases are at least 10-fold
higher than those for FKBPs (for overview see [41]); and, sec-
ond, some FKBPs’ PPIase activities are highly regulated and
might, therefore, exist in their inactive state in the lysate [42].
In general it was observed that neither the PPIase activity orig-
inated by FKBP nor by cyclophilins was changed by the Pin1
knockout (Figs. 4, 5).
The broader substrate speciﬁcity of the cyclophilins allows
the catalysis of phosphorylated substrates [4]. We could ob-
serve that cyclosporine A inhibits all PPIase activity measured
with the phosphorylated substrate in Pin1/ lysates. The same
increase in activity was measured with this substrate in WT
and Pin1/ lysates, if no cyclosporin A was added to the reac-
tion mixture. It can be concluded that the total activity of
cyclophilins is unchanged in the Pin1/ lysates when they
are measured with the phosphorylated substrate. This is in
agreement with the observation that the total cyclophilin activ-
ities as well as the mRNA levels of these enzymes are not chan-
ged as a result of the Pin1 knockout (Figs. 4, 7). The total
cyclophilin activities of the diﬀerent tissues do not show a
strong variance; nevertheless, the phenotypes are present in
some but not all tissues. This fact argues against the possibility
that cyclophilins speciﬁcally substitute for Pin1 activity. But,
the basal activity towards phosphorylated substrates could
be responsible for the general viability of the diﬀerent cell-
types. It has been already reported that extremely small
amounts of ESS1 are suﬃcient to overcome the lethal pheno-
type of the ESS1 knockout in yeast [43]. Such a small amount
of Pin1 activity could similarly be mimiced by cyclophilins.
Since, in the presence of cyclosporine A, no activity could be
found with the phosphorylated substrate in Pin1/ lysates, we
could conclude that under the conditions used here, FKBPs
are not able to catalyze the cis to trans isomerization of this
substrate. Yet, we can not entirely exclude the idea that the
FKBP activity is only observable with the native in vivo sub-
strates or that the activity in general might be too small to
be detected by our methods while being high enough to substi-
tute for Pin1.
Only the total activity of FKBPs and Cyclophilins can be
tested with this assay. We found that the mRNA levels of most
PPIases are unchanged for both Pin1+/+ and Pin1/ animals,
excluding the possibility that the lack of activity diﬀerences be-
tween WT and knockout mice is accidentally caused by a
simultaneous up and down regulation of diﬀerent PPIases.
The real time PCR proﬁles show that no PPIases are exclu-
sively more highly expressed in lung, liver, and MEF, as one
3244 J. Fangha¨nel et al. / FEBS Letters 580 (2006) 3237–3245would expect, if PPIases speciﬁcally prevented the develop-
ment of Pin1 knockout phenotypes. The higher expression lev-
els of Fkbp6 found in the brain of Pin1/ and Fkbp7 in the
MEF of Pin1/ animals have no obvious eﬀects on the PPIase
activity against in vitro substrates. In the case of Fkbp6, this
could be explained by the lower expression level of this protein
in the brain (Fig. 8). Interestingly, despite the lack of any se-
quence homology, a striking resemblance between the tertiary
protein structures of the FKBP and the parvulin family has
previously been observed [5,44]. Furthermore, it was observed
that many essential active side residues are conserved between
parvulins and FKBP [41,45]. Here we could ﬁnd that the loop
between the b5 and b6 sheets of the second FKBP domains of
Fkbp5 and Fkbp4 (FKBP51/52) and FKBP14 shows a high
similarity to the phosphate speciﬁcity determining loop of
Pin1. These ﬁndings open a new way to view FKBPs and their
possible function in catalyzing the peptidyl prolyl cis/trans
isomerization in phosphorylated substrates; these enzymes
might, in contrast to cyclophilins, be highly speciﬁc for such
substrates. The FKBP4, FKBP5 and FKBP14 have a sequence
that could be the equivalent of the phosphate binding loop of
PIN1. That should be proven with recombinant enzyme and
phosphorylated substrates.Further investigations will clarify
our hypothesis.
To summarize our results and earlier observations, it seems
that the lethal phenotype related to the control of the cell cycle
of Pin1 observed in single cell organisms can be overcome by a
basal level of PPIase activity of cyclophilins or by a speciﬁc in-
crease in the expression of certain FKBPs (such as Fkbp6 and
Fkbp7) in higher organisms. The structural similarities of
FKBP51/52 and FKBP also open the possibility that these
PPIases could catalyze phosphorylated substrates. To carry
out such functions, very low amounts of Pin1 and, therefore,
very little PPIase activity towards ligands with (pS/pT)-P mo-
tifs have been shown to be suﬃcient. In organs, such as the
brain and testis, where higher levels of Pin1 activity can be
found, this basal activity is not suﬃcient to substitute for the
missing Pin1 activity resulting in the development of Pin1-spe-
ciﬁc phenotypes.
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